JG

Jacqueline Grant

Executive Fellow at Harvard Business School

Boston, Massachusetts

Overview 

Jacqueline Grant is a Biotech Investor at Abingworth in Boston, Massachusetts, with a background in neuroscience and a strong focus on bioTech investments. She has held key roles at prestigious organizations like Harvard Business School and Genentech, and has served on the boards of companies like Nido Biosciences and Atsena Therapeutics. With a Ph.D. from Stanford University School of Medicine and an MBA from Stanford University Graduate School of Business, Jacqueline has excelled in strategic planning and business development, and has made impactful investments in companies such as Atsena Therapeutics at the Series A stage.

Work Experience 

HB

Harvard Business School

  • Executive Fellow

    2023 - Current

    Guest lecturer and creator of educational content for VC/entrepreneurship/life sciences.

NB

Nido Biosciences

  • Member Board of Directors

    2020

Nido Biosciences is a clinical-stage company that develops precision medicines for severe neurological diseases.

Raised $109,000,000.00 from Bioluminescence Ventures.

nidobio.com
AT

Atsena Therapeutics

  • Member Board of Directors

    2021

Atsena Therapeutics is a clinical-stage gene therapy company that develops novel treatments for inherited forms of blindness.

Raised $87,624,387.00 from Hatteras Venture Partners, Manning Family Foundation, Lightstone Ventures, Retinal Degeneration Fund, Sofinnova Investments, Abingworth, OUP (Osage University Partners), University of Florida, PBM Capital Group and OUP (Osage University Partners).

atsenatx.com
GI

Glycomine Inc.

  • Member Board of Directors

    2022

Glycomine is an early-stage biotech working on replacement therapies for rare diseases.

Raised $80,000,000.00 from Mission BioCapital, Sanofi Ventures, Remiges Ventures, Chiesi Ventures, RiverVest, Novo Holdings, Abingworth, Sanderling Ventures, Asahi Kasei and Asahi Kasei.

glycomine.com
AB

Anjarium Biosciences

  • Board Observer

    2021

A

Abingworth

  • Principal

    2018

SL

SV Life Sciences

  • Senior Associate

    2017 - 2018

SV Health Investors is a boston-based venture capital firm focused on investments in biotechnology and healthcare industry.

svhealthinvestors.com
G

Genentech

  • Senior Manager, Business Development

    2016 - 2016

  • Manager Business Development

    2015 - 2016

  • Associate, Business Development

    2014 - 2015

Genentech specializes in genetic testing and personalized medicine.

gene.com
G

Genentech

  • MBA Marketing & Commercialization Intern

    2013 - 2013

Genentech specializes in genetic testing and personalized medicine.

gene.com
SU

Stanford University

  • PhD Neuroscience

    2008 - 2012

    Faculty Advisor: Larry Steinman Utilize transgenic mouse models, in vivo and in vitro molecular and cellular techniques to study the disease pathogenesis and discover therapeutic agents for Multiple Sclerosis and Alzheimer’s disease. Grant et al., Science Translational Medicine, 08/01/12 Reversal of Paralysis and Reduced Inflammation from Peripheral Administration of β-Amyloid in TH1 and TH17 Versions of Experimental Autoimmune Encephalomyelitis

Education 

Investments 

Atsena Therapeutics

Series A

Total funding: $55M

Articles About Jacqueline

Relevant Websites